FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317862873> ?p ?o ?g. }

• W4317862873 endingPage "656" @default.
• W4317862873 startingPage "656" @default.
• W4317862873 abstract "656 Background: The impact of specific genomic alterations in advanced GI neuroendocrine malignancies on prognosis and treatment decisions has not been fully characterized. In this study, we seek to evaluate next-generation sequencing (NGS) panels and corresponding clinical outcomes in patients with metastatic GI NET/NEC. Methods: Patients with GI-NET/NEC were identified from a database of NGS reports performed at the Cleveland Clinic, and clinical variables were extracted by chart review through an IRB-approved protocol. We provide an analysis of this cohort. Results: Of a total n=45 patients, 53% were male. Median age at diagnosis was 60 (range: 35-90 years) and 82% were non-Hispanic white, while 9% were black. There were n=25 GI-NETs, mostly intermediate or high grade (11 G3, 7 G2), and n=20 GI-NECs. There was a balanced distribution of primary sites, including colorectal (27%), pancreas (24%), small intestine (18%), unknown primary (24%) and a single case of biliary primary. High grade GI-NETs and GI-NECs were over-represented in the colorectal primary group vs other sites. (n=10 of 12; p=0.021). The majority of patients (73%) had at least one somatic variant, including 12 patients (27%) with one or more mutations deemed actionable, but only one patient (with MSH2 mutation) has received a mutation-matched drug (pembrolizumab). Some recurrent alterations appeared to co-segregate with aggressive histology (NEC vs NET), including 12 of 13 TP53 mutations (p<0.05 by Fisher Exact Test), 7 of 8 RB1 (p<0.05), and 5 of 6 APC (p=0.074). The most common mutations per person based on primary site is shown. Microsatellite instability high was rare (n=1) and median tumor mutational burden (TMB) was 3/mb, with TMB lower in NETs vs NECs. A number of patients (35%) underwent germline testing, with 6 of 16 having a pathogenic germline variant. Conclusions: As 42% of the 12 patients with actionable mutations were alive at time of analysis, it is possible that additional patients could be treated with mutation-matched therapies. More input will be needed from providers as to the role played by alternative effective treatments and barriers such as insurance coverage and prior authorization to implementing mutation-matched therapies. Given the overall low TMB of GI-NETs, with several tumors having zero or 1 reported mutation on targeted NGS, whole genome sequencing may prove useful. Finally, certain mutations such as RB1 and TP53 were associated with more aggressive histology (i.e. NEC). Lastly, only 9% of our cohort with NGS were black, a significant under-representation based on epidemiological data, which raises concerns about disparate accessibility and barriers to NGS testing. Further studies are needed to address any possible racial disparity.[Table: see text]" @default.
• W4317862873 created "2023-01-25" @default.
• W4317862873 creator A5003799076 @default.
• W4317862873 creator A5020157550 @default.
• W4317862873 creator A5023582019 @default.
• W4317862873 creator A5039574165 @default.
• W4317862873 creator A5039576853 @default.
• W4317862873 creator A5047856599 @default.
• W4317862873 creator A5091789125 @default.
• W4317862873 date "2023-02-01" @default.
• W4317862873 modified "2023-10-04" @default.
• W4317862873 title "The genomic landscape of advanced gastrointestinal (GI) neuroendocrine tumors (NET) and carcinomas (NEC)." @default.
• W4317862873 doi "https://doi.org/10.1200/jco.2023.41.4_suppl.656" @default.
• W4317862873 hasPublicationYear "2023" @default.
• W4317862873 type Work @default.
• W4317862873 citedByCount "0" @default.
• W4317862873 crossrefType "journal-article" @default.
• W4317862873 hasAuthorship W4317862873A5003799076 @default.
• W4317862873 hasAuthorship W4317862873A5020157550 @default.
• W4317862873 hasAuthorship W4317862873A5023582019 @default.
• W4317862873 hasAuthorship W4317862873A5039574165 @default.
• W4317862873 hasAuthorship W4317862873A5039576853 @default.
• W4317862873 hasAuthorship W4317862873A5047856599 @default.
• W4317862873 hasAuthorship W4317862873A5091789125 @default.
• W4317862873 hasConcept C121608353 @default.
• W4317862873 hasConcept C126322002 @default.
• W4317862873 hasConcept C143998085 @default.
• W4317862873 hasConcept C191093355 @default.
• W4317862873 hasConcept C2779066768 @default.
• W4317862873 hasConcept C2781187634 @default.
• W4317862873 hasConcept C526805850 @default.
• W4317862873 hasConcept C71924100 @default.
• W4317862873 hasConcept C72563966 @default.
• W4317862873 hasConcept C90924648 @default.
• W4317862873 hasConceptScore W4317862873C121608353 @default.
• W4317862873 hasConceptScore W4317862873C126322002 @default.
• W4317862873 hasConceptScore W4317862873C143998085 @default.
• W4317862873 hasConceptScore W4317862873C191093355 @default.
• W4317862873 hasConceptScore W4317862873C2779066768 @default.
• W4317862873 hasConceptScore W4317862873C2781187634 @default.
• W4317862873 hasConceptScore W4317862873C526805850 @default.
• W4317862873 hasConceptScore W4317862873C71924100 @default.
• W4317862873 hasConceptScore W4317862873C72563966 @default.
• W4317862873 hasConceptScore W4317862873C90924648 @default.
• W4317862873 hasIssue "4_suppl" @default.
• W4317862873 hasLocation W43178628731 @default.
• W4317862873 hasOpenAccess W4317862873 @default.
• W4317862873 hasPrimaryLocation W43178628731 @default.
• W4317862873 hasRelatedWork W2019279330 @default.
• W4317862873 hasRelatedWork W2049754458 @default.
• W4317862873 hasRelatedWork W2054122365 @default.
• W4317862873 hasRelatedWork W2313360580 @default.
• W4317862873 hasRelatedWork W2350493697 @default.
• W4317862873 hasRelatedWork W2758868699 @default.
• W4317862873 hasRelatedWork W2972884351 @default.
• W4317862873 hasRelatedWork W3026015583 @default.
• W4317862873 hasRelatedWork W3180628252 @default.
• W4317862873 hasRelatedWork W2588285805 @default.
• W4317862873 hasVolume "41" @default.
• W4317862873 isParatext "false" @default.
• W4317862873 isRetracted "false" @default.
• W4317862873 workType "article" @default.